Back

Impaired cardiac BCAA catabolism associated with impaired myocardial efficiency during exercise in a porcine model with multiple risk factors

26 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Myocardial remodelling (2) Heart Failure ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Miss Lotte Maria Zandbergen

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Assessment of global and segmental strain in heterozygous APE1/Ref-1 transgenic mice using cardiac magnetic resonance imaging
Doctor S. An (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Diastolic dysfunction is associated with cardiac small vessel disease in ovariectomized females but not in males.
Doctor L. Cornuault (Pessac, FR)
Abstract Slides Video
Presentation thumbnail
Thrombosis in the coronary microvasculature may be responsible for impaired cardiac relaxation and diastolic dysfunction
Mr P. Rouault (Pessac, FR)
Abstract Slides Video
Presentation thumbnail
High fat diet rewires cardiac metabolism and restores cardiac function experimental heart failure
Mr C. Galan (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Characterisation of pomegranate juice polyphenols identifies oenothein B as an endothelium-dependent vasodilator and regulator of endothelial function that enhances actions of oligomeric procyanidins
Professor R. Corder (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial remodelling (2)

The Event

Event poster

ESC Congress 2023

26 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Mitochondrial dysfunction as a contributor to decreased perfusion in heart failure with preserved ejection franction(HFpEF) in a swine model of kidney disease and diabetes
thumbnail
Congress Presentation
Multicellular trajectories leading to subclinical diastolic dysfunction and HFpEF progression in cardiometabolic comorbidities.
thumbnail
Congress Presentation
Beneficial effects of treatment with a soluble guanylate cyclase stimulator on cardiac function and mitochondrial activity in an animal model of early-stage HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources